Capital Insight Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-25,782
| Closed | -$1.3M | – | 81 |
|
|
2018
Q2 | $1.3M | Buy |
25,782
+708
| +3% | +$35.7K | 1.07% | 44 |
|
|
2018
Q1 | $1.23M | Buy |
25,074
+2,856
| +13% | +$140K | 1% | 48 |
|
|
2017
Q4 | $985K | Sell |
22,218
-2,605
| -10% | -$115K | 0.77% | 58 |
|
|
2017
Q3 | $1.26M | Sell |
24,823
-20,539
| -45% | -$1.04M | 1.06% | 48 |
|
|
2017
Q2 | $2.45M | Sell |
45,362
-1,696
| -4% | -$91.4K | 2.17% | 17 |
|
|
2017
Q1 | $2.48M | Buy |
47,058
+15,497
| +49% | +$817K | 2.25% | 14 |
|
|
2016
Q4 | $1.52M | Sell |
31,561
-12,489
| -28% | -$601K | 1.51% | 31 |
|
|
2016
Q3 | $2.38M | Sell |
44,050
-3,812
| -8% | -$206K | 2.28% | 19 |
|
|
2016
Q2 | $2.59M | Sell |
47,862
-787
| -2% | -$42.6K | 2.46% | 16 |
|
|
2016
Q1 | $2.47M | Buy |
48,649
+643
| +1% | +$32.6K | 2.51% | 17 |
|
|
2015
Q4 | $2.42M | Buy |
48,006
+8,816
| +22% | +$445K | 2.45% | 17 |
|
|
2015
Q3 | $1.88M | Buy |
39,190
+5,653
| +17% | +$272K | 1.77% | 31 |
|
|
2015
Q2 | $1.75M | Buy |
+33,537
| New | +$1.75M | 1.48% | 36 |
|